---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-021470"
form_type: "8-K"
ticker: "AURX"
cik: "0001091596"
company_name: "Nuo Therapeutics, Inc."
filed_at: "2022-08-30T23:59:59+00:00"
generated_at: "2026-06-23T19:11:43.506512+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuo Therapeutics secures $500K equity investment from distributor Pacific Medical; raises $4.5M YTD

## Summary
- PacMed invests $500K for 500K shares at $1.00; receives two warrants for up to 450K shares tied to sales quotas.
- PacMed can earn up to 300K milestone shares if cumulative sales reach $4.5M–$12.5M over 2024–2025 periods.
- Company raised ~$4.5M in working capital equity in 2022, including this deal, to support Aurix commercial re-launch.
- Distribution network covers ~30% of U.S. population via 10 entities; PacMed contributes over 40 sales representatives.
- Stock approved for OTCQB trading; uplisting to national securities exchange considered as a future option.

## SEC filing metadata
- accession: 0001437749-22-021470
- form_type: 8-K
- ticker: AURX
- cik: 0001091596
- company_name: Nuo Therapeutics, Inc.
- filed_at: 2022-08-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1091596/000143774922021470/0001437749-22-021470-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1091596/000143774922021470/aurx20220824b_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-021470
- JSON: https://secwatch.observer/filing/0001437749-22-021470.json
- Plain text: https://secwatch.observer/filing/0001437749-22-021470.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.